Cancer Letters 1993: Vol 69 Index

7 Pages·1993·1.6 MB·English

Cancer Letters, 69 (1993) 209-211
Elsevier Scientific Publishers Ireland Ltd.
Subject Index
Volume 69
aflatoxin B,, methyl-deficient diet, rat liver, serum enzymes, chemoprevention, alpha-antitrypsin, rat intestinal tumors,
necrosis, lipidosis, 93 azoxymethane, 39
alpha-antitrypsin, rat intestinal tumors, azoxymethane, chemoprevention, green tea, catechins, tumor promotion, car-
chemoprevention, 39 cinogenesis, gap junctions, 15
amino acids alcohols, differentiation, growth inhibition, colon tumor cell differentiation, bile acids, deoxycholate, 181
melanoma, 203 colony formation, vinblastine, TN-16, renal carcinoma cells,
animal lectins, cell-cycle kinetics, gene expression, 67 soybean trypsin inhibitor, in vitro invasion assay, 85
anticancer effect, polyamine uptake, spermidine, spermine, or- cotinine, urine mutagenicity, tobacco habits, 75
nithine decarboxylase, S-adenosylmethionine decarboxylase, cyclophosphamide, autochthonous murine mammary tumors,
a-difluoromethylornithine, L1210 leukemia, 33 MMTV, enterovirus, immune tolerance, host control of
antigen, sarcoma, purification, sarcoma antigen, 173 cancer, 133
antisense, neu, oncogene, neuroblastoma, 27 cyclosporin A, P-glycoprotein, mdr genes, natural killer cells,
autochthonous murine mammary tumors, MMTV, enterovirus, multiple drug resistance, 139
immune tolerance, cyclophosphamide, host control of cytochromeP-450, methylbutylnitrosamine, nitrosamine, eso-
cancer, 133 phagus, liver microsomes, monoclonal antibody, 107
azoxymethane, alpha-antitrypsin, rat intestinal tumors, chemo- cytokines, heparin, transformation, soft agar, 197
Prevention, 39
deoxycholate, bile acids, colon tumor cell differentiation, 181
basement membrane, invasion, human assay, extracellular ma- diagnostics of cancer, fluorescent dyes, induced tumors, human
trix, 123 gastric cancer, 117
benzoyl peroxide, biomimetic superoxide dismutase, promo- dietary fat, transgenic mice, oncogene amplification, hypo-
tion, progression, skin tumors, 167 methylation, 59
bile acids, deoxycholate, colon tumor cell differentiation, 181 differentiation, amino acids alcohols, growth inhibition, mel-
biomimetic superoxide dismutase, benzoyl peroxide, promo- anoma, 203
tion, progression, skin tumors, 167 a-difluoromethylornithine, polyamine uptake, spermidine,
bleomycin, electrotherapy, fibrosarcoma experimental, 81 spermine, ornithine decarboxylase, S-adenosylmethionine
breast cyst fluid, cathepsin D, pS2, oestradiol, 21 decarboxylase, L1210 leukemia, anticancer effect, 33
c-Ha-ras, oncogene product, protease inhibitor, cathepsin, 161 electrotherapy, bleomycin, fibrosarcoma experimental, 81
cancer risk assessment, pharmacokinetics, physiological enterovirus, autochthonous murine mammary tumors, MMTV,
models, metabolism, tissue binding, tissue reactivity, chemi- immune tolerance, cyclophosphamide, host control of
cal carcinogenesis, pharmacodynamics, tissue dosimetry, cancer, 133
sensitivity analysis, | (-)-epicatechin, chemical carcinogenesis, glutathione levels,
carcinogenesis, green tea, catechins, tumor promotion, gap Saraka asoca, 45
junctions, chemoprevention, 15 esophagus, methylbutylnitrosamine, nitrosamine, liver micro-
catechins, green tea, tumor promotion, carcinogenesis, gap somes, cytochromeP-450, monoclonal antibody, 107
junctions, chemoprevention, 15 extracellular matrix, invasion, human assay, basement mem-
cathepsin D, pS2, oestradiol, breast cyst fluid, 21 brane, 123
cathepsin, c-Ha-ras, oncogene product, protease inhibitor, 161
cell-cycle kinetics, animal lectins, gene expression, 67 fibrosarcoma experimental, bleomycin, electrotherapy, 81
chemical carcinogenesis, glutathione levels, Saraka asoca, (-)- fluorescent dyes, induced tumors, human gastric cancer,
epicatechin, 45 diagnostics of cancer, 117
chemical carcinogenesis, pharmacokinetics, physiological
models, metabolism, tissue binding, tissue reactivity, cancer gap junctions, green tea, catechins, tumor promotion, car-
risk assessment, pharmacodynamics, tissue dosimetry, sensi- cinogenesis, chemoprevention, 15
tivity analysis, | gene expression, animal lectins, cell-cycle kinetics, 67
210
glutathione levels, chemical carcinogenesis, Saraka asoca, (-)- methyl-deficient diet, aflatoxin B,, rat liver, serum enzymes,
epicatechin, 45 necrosis, lipidosis, 93
granulocyte-macrophage colony stimulating factor, transferrin, methylbutylnitrosamine, nitrosamine, esophagus, liver micro-
insulin, myeloid leukemia, receptor trafficking, hyperos- somes, cytochromeP-450, monoclonal antibody, 107
molar medium, 51 MMTYV, autochthonous murine mammary tumors, enterovirus,
green tea, catechins, tumor promotion, carcinogenesis, gap immune tolerance, cyclophosphamide, host control of
junctions, chemoprevention, 15 cancer, 133
growth inhibition, amino acids alcohols, differentiation, Molt-4, interleukin-2, polyphenols, IM-9 cells, 191
melanoma, 203 monoclonal antibody, methylbutylnitrosamine, nitrosamine,
esophagus, liver microsomes, cytochromeP-450, 107
heparin, cytokines, transformation, soft agar, 197 multiple drug resistance, P-glycoprotein, mdr genes, natural
host control of cancer, autochthonous murine mammary tu- killer cells, cyclosporin A, 139
mors, MMTV, enterovirus, immune tolerance, cyclophos- myeloid leukemia, transferrin, insulin, granulocyte-macro-
phamide, 133 phage colony stimulating factor, receptor trafficking,
human assay, invasion, extracellular matrix, basement mem- hyperosmolar medium, 51
brane, 123
human gastric cancer, fluorescent dyes, induced tumors, natural killer cells, P-glycoprotein, mdr genes, multiple drug re-
diagnostics of cancer, 117 sistance, cyclosporin A, 139
hyperosmolar medium, transferrin, insulin, granulocyte- necrosis, aflatoxin B,, methyl-deficient diet, rat liver, serum
macrophage colony stimulating factor, myeloid leukemia, enzymes, lipidosis, 93
receptor trafficking, 51 neu, antisense, oncogene, neuroblastoma, 27
hypomethylation, dietary fat, transgenic mice, oncogene am- neuroblastoma, meu, antisense, oncogene, 27
plification, 59 nitrosamine, methylbutylnitrosamine, esophagus, liver micro-
somes, cytochromeP-450, monoclonal antibody, 107
IM-9 cells, interleukin-2, polyphenols, Molt-4, 191
immune tolerance, autochthonous murine mammary tumors, oestradiol, cathepsin D, pS2, breast cyst fluid, 21
MMTYV, enterovirus, cyclophosphamide, host control of oncogene amplification, dietary fat, transgenic mice, hypo-
cancer, 133 methylation, 59
ohistochemistry, sequencing, p53, pancreatic cancer, oncogene product, c-Ha-ras, protease inhibitor, cathepsin, 161
151 oncogene, neu, antisense, neuroblastoma, 27
in vitro invasion assay, vinblastine, TN-16, renal carcinoma ornithine decarboxylase, polyamine uptake, spermidine, sper-
cells, soybean trypsin inhibitor, colony formation, 85 mine, S-adenosylmethionine decarboxylase, a-difluoro-
induced tumors, fluorescent dyes, human gastric cancer, methylornithine, L1210 leukemia, anticancer effect, 33
diagnostics of cancer, 117
insulin, transferrin, granulocyte-macrophage colony stimulat- P-glycoprotein, mdr genes, natural killer cells, multiple drug re-
ing factor, myeloid leukemia, receptor _ trafficking, sistance, cyclosporin A, 139
hyperosmolar medium, 51 p53, immunohistochemistry, sequencing, pancreatic cancer,
interleukin-2, polyphenols, Molt-4, IM-9 cells, 191 151
invasion, human assay, extracellular matrix, basement mem- pancreatic cancer, immunohistochemistry, sequencing, p53,
brane, 123 151
pharmacodynamics, pharmacokinetics, physiological models,
L1210 leukemia, polyamine uptake, spermidine, spermine, or- metabolism, tissue binding, tissue reactivity, chemical car-
nithine decarboxylase, S-adenosylmethionine decarboxylase, cinogenesis, cancer risk assessment, tissue dosimetry, sensi-
a-difluoromethylornithine, anticancer effect, 33 tivity analysis, |
lipidosis, aflatoxin B,, methyl-deficient diet, rat liver, serum pharmacokinetics, physiological models, metabolism, tissue
enzymes, necrosis, 93 binding, tissue reactivity, chemical carcinogenesis, cancer
liver microsomes, methylbutylnitrosamine, nitrosamine, risk assessment, pharmacodynamics, tissue dosimetry, sensi-
esophagus, cytochromeP-450, monoclonal antibody, 107 tivity analysis, |
physiological models, pharmacokinetics, metabolism, tissue
mammary tumor, thymosin a, 187 binding, tissue reactivity, chemical carcinogenesis, cancer
mdr genes, P-glycoprotein, natural killer cells, multiple drug re- risk assessment, pharmacodynamics, tissue dosimetry, sensi-
sistance, cyclosporin A, 139 tivity analysis, |
melanoma, amino acids alcohols, differentiation, growth in- polyamine uptake, spermidine, spermine, ornithine decarbox-
hibition, 203 ylase, S-adenosylmethionine decarboxylase, a -difluoro-
metabolism, pharmacokinetics, physiological models, tissue methylornithine, L1210 leukemia, anticancer effect, 33
binding, tissue reactivity, chemical carcinogenesis, cancer polyphenols, interleukin-2, Molt-4, IM-9 cells, 191
risk assessment, pharmacodynamics, tissue dosimetry, sensi- progression, benzoyl peroxide, biomimetic superoxide dismut-
tivity analysis, 1 ase, promotion, skin tumors, 167
211
promotion, benzoyl peroxide, biomimetic superoxide dis- spermidine, polyamine uptake, spermine, ornithine decarboxy-
mutase, progression, skin tumors, 167 lase, S-adenosylmethionine decarboxylase, a-difluorometh-
protease inhibitor, c-Ha-ras, oncogene product, cathepsin, 161 ylornithine, L1210 leukemia, anticancer effect, 33
pS2, cathepsin D, oestradiol, breast cyst fluid, 21 spermine, polyamine uptake, spermidine, ornithine decarbox-
purification, sarcoma, antigen, sarcoma antigen, 173 ylase, S-adenosylmethionine decarboxylase, a-difluorometh-
ylornithine, L1210 leukemia, anticancer effect, 33
rat intestinal tumors, alpha-antitrypsin, azoxymethane, chemo-
prevention, 39 thymosin a,, mammary tumor, 187
rat liver, aflatoxin B,, methyl-deficient diet, serum enzymes, tissue binding, pharmacokinetics, physiological models, metab-
necrosis, lipidosis, 93 olism, tissue reactivity, chemical carcinogenesis, cancer risk
receptor trafficking, transferrin, insulin, granulocyte-macro- assessment, pharmacodynamics, tissue dosimetry, sensitivity
phage colony stimulating factor, myeloid leukemia, analysis, 1
hyperosmolar medium, 51 tissue dosimetry, pharmacokinetics, physiological models, me-
renal carcinoma cells, vinblastine, TN-16, soybean trypsin inhi- tabolism, tissue binding, tissue reactivity, chemical car-
bitor, in vitro invasion assay, colony formation, 85 cinogenesis, cancer risk assessment, pharmacodynamics,
sensitivity analysis, 1
S-adenosylmethionine decarboxylase, polyamine uptake, sper- tissue reactivity, pharmacokinetics, physiological models, me-
midine, spermine, ornithine decarboxylase, a-difluorome- tabolism, tissue binding, chemical carcinogenesis, cancer risk
thylornithine, L1210 leukemia, anticancer effect, 33 assessment, pharmacodynamics, tissue dosimetry, sensitivity
Saraka asoca, chemical carcinogenesis, glutathione levels, (-)- analysis, 1
epicatechin, 45 TN-16, vinblastine, renal carcinoma cells, soybean trypsin inhi-
sarcoma antigen, sarcoma, antigen, purification, 173 bitor, in vitro invasion assay, colony formation, 85
sarcoma, antigen, purification, sarcoma antigen, 173 tobacco habits, cotinine, urine mutagenicity, 75
sensitivity analysis, pharmacokinetics, physiological models, transferrin, insulin, granulocyte-macrophage colony stimulat-
metabolism, tissue binding, tissue reactivity, chemical car- ing factor, myeloid leukemia, receptor trafficking,
cinogenesis, cancer risk assessment, pharmacodynamics, tis- hyperosmolar medium, 51
sue dosimetry, 1 transformation, heparin, cytokines, soft agar, 197
sequencing, immunohistochemistry, p53, pancreatic cancer, transgenic mice, dietary fat, oncogene amplification,
151 hypomethylation, 59
serum enzymes, aflatoxin B,, methyl-deficient diet, rat liver, tumor promotion, green tea, catechins, carcinogenesis, gap
necrosis, lipidosis, 93 junctions, chemoprevention, 15
skin tumors, benzoyl peroxide, biomimetic superoxide
dismutase, promotion, progression, 167 urine mutagenicity, cotinine, tobacco habits, 75
soft agar, heparin, cytokines, transformation, 197
soybean trypsin inhibitor, vinblastine, TN-16, renal carcinoma vinblastine, TN-16, renal carcinoma cells, soybean trypsin inhi-
cells, in vitro invasion assay, colony formation, 85 bitor, in vitro invasion assay, colony formation, 85

Cancer Letters, 69 (1993) 213-214
Elsevier Scientific Publishers Ireland Ltd.
Author Index
Volume 69
Akin, C. Hiwasa, T.
Andersen, M.E. Huang, Q.
Ask, A. Hurst, R.E.
Askew, D.
Igawa, T.
Babcook, D.M.
Barsoum, A.L. Kanda, S.
Beger, H.G. Kanetake, H.
Bhisey, R.A. Kaufman, D.G.
Biggs, M.W. Kawamura, M.
Braginskaja, O.V. Kennedy, J.W.
Buchler, M. Kobrin, M.S.
Burger, C.J. Koide, H.
Bynum, R.L. Korc, M.
Krewski, D.
Campbell, J.S. Kurl, R.N.
Casey, G.
Chang, S.-H. La LX.
Chang, W.-C. Lai, M.-D.
Chen, S.C. Landau, O.
Chiou, S.-T. Lanfranchi, H.
Cornell, C. Laver, G.W.
Lazarev, V.V.
Das, N.P. Lennard, T.W.J.
Desai, T.K. Lopez, M.E.
Deutsch, A.A.
Devi, M.A. Mehta, R.
Duran, H.A. Miklavcic, D.
Miller, Y.
Eiselein, J.E. Mirvish, S.S.
Elgert, K.D. Morin, M.J.
Mueller, R.
Farmer, S.J.
Feit, C. Nair, S.C.
Friess, H. Nakamura, M.
Fujita-Y oshigaki, J. Nathan, D.F.
Naylor, P.H.
Gekeler, V. Niethammer, D.
Gelboin, H.V. Noller, A.
Ghose, T. Nordenberg, J.
Goodly, L.J. Novakovic, S.
Govekar, R.B. Novogrodsky, A.
Gupta, N.K. Niissler, V.
Handgretinger, R. Palmieri, M.A.
Heby, O. Panet, H.
Hirshaut, Y. Panikkar, B.
214
Panikkar, K.R. Siegal, G.P.
Park, S.S. Sigler, K.
Perrson, L. Singh, R.K.
Polsachev, V.I. Sonnenfeld, G.
Probst, H. Stapley, R.
Steinmeyer, C.
Reddy, B.S. Stoskii, V.E.
Reiss, R.
de Rey, B.M. Varghese, C.D.
Rhodes, S.W.
Rijhsinghani, K.
Waddell, K.
Rinehart, C.A.
Wang, M.-H.
Rubin, L.B.
Wang, S.
Ruch, R.J.
Wasserman, L.
Weger, S.
Saito, Y.
Wilisch, A.
Sakiyama, S.
Sawada, T.
Schmall, B. De Wille, J.W.
Seiler, N. Withey, J.R.
Sersa, G.
Shaw, Y.-T. Yamanaka, Y.
Shirouzu, M. Yokoyama, S.